W. Ludo van der Pol - Concepedia

Author

W. Ludo van der Pol

Also Known As

Crg Schreurs, Ludo Van Der Pol, Ludo W. van der Pol, Tetsuo Kobayashi, W -Ludo van der Pol, W L Van Der Pol, W L van der Pol, W Ludo Van der Pol, W Ludo van der Pol, W-Ludo Van Der Pol2

202

Publications

6.3K

Citations

H-Index

136

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Wilhelmina Children's Hospital Radboud University Nijmegen Radboud University Medical Center

About

W. Ludo van der Pol is an author at University Medical Center Utrecht specializing in medicine, immunology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.6K
2	Health Sciences	7	7	215
3	Public Health	2	2	84
4	Nursing	1	1	38
5	Social Sciences	1	1	365

W. Ludo van der Pol

102

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling Clare V. Logan, György Szabadkai, Jenny A. Sharpe, Nature Genetics Mitochondrial MyopathyMitochondrial CalciumMuscle DisorderMolecular NeuroscienceMolecular Physiology	2013	365
Muscle strength and motor function throughout life in a cross‐sectional cohort of 180 patients with spinal muscular atrophy types 1c–4 Renske I. Wadman, Camiel A. Wijngaarde, Marloes Stam, European Journal of Neurology	2017	218
VCP mutations in familial and sporadic amyotrophic lateral sclerosis Max Koppers, Marka van Blitterswijk, Lotte Vlam, Neurobiology of Aging Neurodegenerative DiseasesAmyotrophic Lateral SclerosisGenetic DisorderGeneticsNeurology	2011	139
<i><scp>RYR</scp>1</i>‐related myopathies: a wide spectrum of phenotypes throughout life Marc Snoeck, Baziel G.M. van Engelen, Benno Küsters, European Journal of Neurology	2015	138
A natural history study of late onset spinal muscular atrophy types 3b and 4 Sanne Piepers, Leonard H. van den Berg, F. Brugman, Journal of Neurology Neuromusculoskeletal DisorderDegenerative SpineKinesiologySkeletal MuscleDegenerative Disease	2008	134
Activity of Human IgG and IgA Subclasses in Immune Defense Against <i>Neisseria meningitidis</i> Serogroup B Gestur Vidarsson, W. Ludo van der Pol, Jean van den Elsen, The Journal of Immunology	2001	131
Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis Sanne Piepers, Jan H. Veldink, Sonja W. de Jong, Annals of Neurology	2009	118
Hexanucleotide repeat expansions in <i>C9ORF72</i> in the spectrum of motor neuron diseases Wouter van Rheenen, Marka van Blitterswijk, Mark Huisman, Neurology	2012	117
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial Enrico Bertini, Éric Dessaud, Eugenio Mercuri, The Lancet Neurology Placebo-controlled Phase 2Chronic Musculoskeletal ConditionType 2Clinical TrialsSpinal Muscular Atrophy	2017	114
Muscle strength and motor function in adolescents and adults with spinal muscular atrophy Camiel A. Wijngaarde, Marloes Stam, Louise Otto, Neurology	2020	108

Page 1